Inspire Investing’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $393K | Buy |
11,888
+3,337
| +39% | +$110K | 0.04% | 397 |
|
|
2025
Q1 | $344K | Buy |
8,551
+47
| +0.6% | +$1.89K | 0.04% | 559 |
|
|
2024
Q4 | $400K | Buy |
8,504
+616
| +8% | +$29K | 0.04% | 631 |
|
|
2024
Q3 | $416K | Buy |
7,888
+1,317
| +20% | +$69.5K | 0.04% | 377 |
|
|
2024
Q2 | $356K | Buy |
6,571
+1,484
| +29% | +$80.4K | 0.04% | 389 |
|
|
2024
Q1 | $357K | Buy |
5,087
+605
| +13% | +$42.4K | 0.04% | 717 |
|
|
2023
Q4 | $374K | Sell |
4,482
-5,882
| -57% | -$491K | 0.04% | 778 |
|
|
2023
Q3 | $305K | Buy |
10,364
+753
| +8% | +$22.2K | 0.04% | 727 |
|
|
2023
Q2 | $314K | Buy |
9,611
+1,927
| +25% | +$62.9K | 0.04% | 634 |
|
|
2023
Q1 | $270K | Buy |
7,684
+2,521
| +49% | +$88.7K | 0.03% | 762 |
|
|
2022
Q4 | $237K | Buy |
5,163
+828
| +19% | +$37.9K | 0.03% | 420 |
|
|
2022
Q3 | $210K | Sell |
4,335
-1,027
| -19% | -$49.8K | 0.03% | 348 |
|
|
2022
Q2 | $211K | Sell |
5,362
-26,297
| -83% | -$1.03M | 0.03% | 641 |
|
|
2022
Q1 | $1.17M | Buy |
31,659
+26,192
| +479% | +$964K | 0.13% | 145 |
|
|
2021
Q4 | $249K | Sell |
5,467
-1,595
| -23% | -$72.6K | 0.03% | 489 |
|
|
2021
Q3 | $252K | Buy |
+7,062
| New | +$252K | 0.03% | 354 |
|